BMRA biomerica.com: Prakiraan wutah bathi kanggo taun ngarep

Logo korporat perusahaan Biomerica (BMRA)

Biomerica, Inc. (BMRA) develops proprietary InFocus systems for diagnosing gastrointestinal issues, ensuring protection against replication. The integration of InFoods tests into IBS treatment positions the company as a key link in personalized nutrition. Results are driven by the sales of clinical systems, where margins remain stable. Reviewing the projected net income per share growth rate on GURU.Markets, we see that 0.00 reflects the latest value of the metric.

BMRA: Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Biomerica, Inc 04.07.2022 - 17.11.2026

Rincian analitis perusahaan Biomerica, Inc.

- rega lan prakiraan konsensus rega:
Analisis fundamental perusahaan:BMRA, Biomerica, Inc.
Barang utama biomerica.com

This indicator measures the expected earnings per share dynamics, reflecting the business model's sensitivity to macroeconomic shifts and technological updates via the consensus forecast for forward-looking EPS growth rates. The current value of 0.00 confirms the resilience of Biomerica, Inc., as demand for personalized food intolerance diagnostics remains stable regardless of economic cycle phases, ensuring the asset's reliability.

Analisis pesaing Biomerica, Inc.

A (agilent.com) - Prakiraan wutah bathi kanggo taun ngarep|DGX - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ILMN|EXAS - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep RVTY (revvity.com)|Bio-Rad Laboratories (BIO) - Prakiraan wutah bathi resik saben saham ing taun ngarep|Anbio Biotechnology - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep soterahealth.com|QDEL: Prakiraan wutah bathi kanggo taun ngarep|OPKO Health - Dinamika bathi saben saham sing diarepake ing taun ngarep|CDNA (CareDx, Inc) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep MRVI|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Fulgent Genetics (FLGT)|LAB (Standard BioTools Inc.) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep CTKB (Cytek Biosciences)|OraSure Technologies Inc (OSUR) - Prakiraan wutah bathi resik saben saham ing taun ngarep|XGN - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|MDxHealth Inc. - Proyeksi tambahing bathi saben saham ing taun ngarep|LUCD: Prakiraan wutah bathi kanggo taun ngarep|Prenetics Global Limited - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Insight Molecular Diagnostics, Inc.|trinitybiotech.com (TRIB) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep PRPH|Prakiraan wutah bathi kanggo taun ngarep Ainos Corp (AIMD)|Prakiraan wutah bathi kanggo taun ngarep CODX (codiagnostics.com)|Heart Test Laboratories - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|CDIO - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Onconetix Corp (ONCO) - Prakiraan wutah bathi saben saham kanggo taun ngarep|VRAX (Virax Biolabs Group Ltd) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Bluejay Diagnostics Corp (BJDX)|AWH (Aspira Women's Health, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|AXDX - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep centogene.com (CNTG)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Enzo Biochem|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep FRES|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep GTG Labs|23andMe Holding Co - Prakiraan wutah bathi kanggo taun ngarep|PMD - Prakiraan wutah bathi kanggo taun ngarep